Search results
Results From The WOW.Com Content Network
Alleged violations included false advertisement and inaccurate blood testing. Theranos agreed to refund $4.65 million to the state's residents for Theranos blood testing services, providing a refund to every resident who had received a test, regardless of whether the test results were voided or corrected. [84] [85] [86] [87]
Elizabeth Anne Holmes (born February 3, 1984) is an American biotechnology entrepreneur who was convicted of fraud in connection with her blood-testing company, Theranos. [2] The company's valuation soared after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a ...
Arizona brought an ACFA case against Theranos, reaching a $4.65 million settlement in 2017. Arizona consumers who were affected received refunds in the mail. The average refund was $60.92. The largest refund was $3,411. Under the terms of the settlement Theranos was banned for two years from blood-testing. [15] [16]
The jury acquitted Holmes on several counts related to accusations Theranos defrauded patients who relied on the company to deliver accurate blood test results, and deadlocked on three others ...
In a four-hour closing argument, the prosecution pointed to numerous alleged misstatements about Theranos' blood-testing technology, which Holmes had suggested could perform hundreds of diagnostic ...
A federal judge on Wednesday denied a request from former Theranos CEO Elizabeth Holmes to keep customer complaints, test results, and a regulatory report out of her upcoming criminal fraud trial ...
In late 2015, Carreyrou began a series of investigative articles on Theranos, published in The Wall Street Journal on the blood-testing startup founded by Elizabeth Holmes. The articles questioned the company's claim to be able to run a wide range of lab tests from a tiny sample of blood from a finger prick.
Theranos promised that a drop of blood could yield many health secrets. RapidEye/E+ via Getty ImagesOne of the most high-profile trials of the year is underway to decide whether Theranos founder ...